I agree that this site is using cookies. You can find further informations here.
X
Quaranta, Sylvie
22  results:
Search for persons X
?
1

La pharmacogénétique, une discipline devenue incontournable:

Picard, Nicolas ; Becquemont, Laurent ; Boyer, Jean-Christophe...
Actualités Pharmaceutiques.  61 (2022)  616 - p. 20-23 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Traitements psychiatriques et pharmacogénétique:

Alarcan, Hugo ; Guilhaumou, Romain ; Quaranta, Sylvie
Actualités Pharmaceutiques.  61 (2022)  616 - p. 27-30 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Correlation between assessment of cytochrome P450 1A2 activ..:

Alarcan, Hugo ; Cannet, Pauline ; Camus, Vincent...
British Journal of Clinical Pharmacology.  89 (2022)  5 - p. 1665-1671 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Renal impairment and DPD testing: Watch out for false‐posit..:

Carriat, Laure ; Quaranta, Sylvie ; Solas, Caroline..
British Journal of Clinical Pharmacology.  88 (2022)  11 - p. 4928-4932 , 2022
Link: https://doi.org/10.1111/..
 
?
5

A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficie..:

Marin, Clémence ; Krache, Anis ; Palmaro, Chloé...
Clinical and Translational Science.  13 (2020)  4 - p. 761-768 , 2020
Link: https://doi.org/10.1111/..
 
?
6

Dépistage du déficit en dihydropyrimidine déshydrogénase (D..:

Loriot, Marie-Anne ; Ciccolini, Joseph ; Thomas, Fabienne...
Bulletin du Cancer.  105 (2018)  4 - p. 397-407 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Ledipasvir and tenofovir drug interaction in human immunode..:

Solas, Caroline ; Bregigeon, Sylvie ; Faucher‐Zaegel, Olivia...
British Journal of Clinical Pharmacology.  84 (2017)  2 - p. 404-409 , 2017
Link: https://doi.org/10.1111/..
 
?
8

UGT1A1 genotype and irinotecan therapy: general review and ..:

Etienne‐Grimaldi, Marie‐Christine ; Boyer, Jean‐Christophe ; Thomas, Fabienne...
Fundamental & Clinical Pharmacology.  29 (2015)  3 - p. 219-237 , 2015
Link: https://doi.org/10.1111/..
 
?
9

Effect of fluid loading during hypovolaemic shock on caspof..:

Roch, Antoine ; Woloch, Christian ; Blayac, Dorothée...
Critical Care.  15 (2011)  5 - p. R219 , 2011
Link: https://doi.org/10.1186/..
 
?
10

Impact of plasma and intracellular exposure and CYP3A4, CYP..:

Guilhaumou, Romain ; Solas, Caroline ; Bourgarel-Rey, Veronique...
Cancer Chemotherapy and Pharmacology.  68 (2011)  6 - p. 1633-1638 , 2011
Link: https://doi.org/10.1007/..
 
?
11

Population pharmacokinetics and pharmacogenetics of vincris..:

Guilhaumou, Romain ; Simon, Nicolas ; Quaranta, Sylvie...
Cancer Chemotherapy and Pharmacology.  68 (2010)  5 - p. 1191-1198 , 2010
Link: https://doi.org/10.1007/..
 
?
12

Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on ..:

Solas, Caroline ; Simon, Nicolas ; Drogoul, Marie‐Pierre...
British Journal of Clinical Pharmacology.  64 (2007)  3 - p. 353-362 , 2007
Link: https://doi.org/10.1111/..
 
?
13

Identification by single-strand conformational polymorphism..:

Quaranta, Sylvie ; Chevalier, Dany ; Bourgarel-Rey, Véronique...
Toxicology Letters.  164 (2006)  2 - p. 177-184 , 2006
Link: https://doi.org/10.1016/..
 
?
14

Genetic polymorphism of the human cytochrome CYP2A13 in a F..:

Cauffiez, Christelle ; Lo-Guidice, Jean-Marc ; Quaranta, Sylvie...
Biochemical and Biophysical Research Communications.  317 (2004)  2 - p. 662-669 , 2004
Link: https://doi.org/10.1016/..
 
?
15

Dépistage du déficit en dihydropyrimidine déshydrogénase (D..:

Loriot, Marie-Anne ; Ciccolini, Joseph ; Thomas, Fabienne...
10.1016/j.bulcan.2018.02.001.  , 2022
Link: https://hdl.handle.net/2..
 
1-15